The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma. IV. Local treatment failure and enucleation in the first 5 years after brachytherapy. COMS report no. 19

Article Outline

• Copyright

With apologies, the authorship on “The COMS Randomized Trial of Iodine 125 Brachytherapy for Choroidal Melanoma. IV. Local Treatment Failure and Enucleation in the First 5 Years after Brachytherapy. COMS Report No. 19” (Ophthalmology 2002;109:2197–206) should have been the Collaborative Ocular Melanoma Study Group*(COMS Group).

• * Members of the COMS Group's Writing Committee are Lee M. Jampol, MD, Claudia S. Moy, PhD, Timothy G. Murray, MD, Sandra M. Reynolds, MA, Daniel M. Albert, MD, Andrew P. Schachat, MD, Kenneth R. Diddie, MD, Robert E. Engstrom, Jr, MD, Paul T. Finger, MD, Kenneth R. Hovland, MD, Leonard Joffe, MD, Karl R. Olsen, MD, and Craig G. Wells, MD.